Van Gorp Eric C M, Setiati Tatty E, Mairuhu Albert T A, Suharti Catharina, Cate Ht Hugo ten, Dolmans Wil M V, Van Der Meer Jos W M, Hack C Erik, Brandjes Dees P M
Department of Internal Medicine, Slotervaart Hospital, Amsterdam, Netherlands.
J Med Virol. 2002 Aug;67(4):549-54. doi: 10.1002/jmv.10137.
The mechanisms contributing to bleeding complications in dengue hemorrhagic fever were studied by investigating the pattern of activation of the coagulation and fibrinolytic systems in 50 children with severe dengue hemorrhagic fever. Thirteen patients (26%) died, and activation of coagulation was most pronounced in the deceased group. Fibrinolysis was also activated, but this activation was relatively weak compared with that of coagulation as a result of persistently high plasminogen activator inhibitor levels. Plasminogen activator inhibitor also prevented a switch from the procoagulant to the profibrinolytic state in lethal dengue hemorrhagic fever, which was further enhanced by an acquired protein C deficiency. The present study is the first to demonstrate such a mechanism in a viral infection. This imbalance between coagulation and fibrinolysis may be used as a prognostic marker, but it may also be a target for future therapeutic intervention.
通过研究50例重症登革出血热患儿凝血和纤维蛋白溶解系统的激活模式,探讨了登革出血热出血并发症的发生机制。13例患者(26%)死亡,凝血激活在死亡组最为明显。纤维蛋白溶解也被激活,但由于纤溶酶原激活物抑制剂水平持续升高,与凝血激活相比,这种激活相对较弱。纤溶酶原激活物抑制剂还阻止了致死性登革出血热从促凝状态向纤溶状态的转变,而获得性蛋白C缺乏进一步加剧了这种转变。本研究首次在病毒感染中证实了这种机制。凝血和纤维蛋白溶解之间的这种失衡可能用作预后标志物,但它也可能成为未来治疗干预的靶点。